Nephrology

Pediatric Hematology/Oncology

Questions discussed in this category

How do you approach patients who are inappropriately worried/fixated on a test result that is flagged as abnormal but not clinically significant?

(i.e., isolated elevation in MCHC, RDW.) Especially when all other lab results are normal and reassuring.

3 Answers available

What is your preferred treatment agent for type 1 von Willebrand patients needing minor procedures if they have a history of severe hyponatremia with DDAVP?

Hyponatremia occurred despite fluid restriction. Do you favor factor replacement? Or do you continue to try DDAVP and add urea +/- salt tablets, in a...

3 Answers available

What strategies do you find helpful in advanced care planning with patients/families who are very "miracle" centered?

For example, prolonging life-sustaining measures as they "wait for a miracle" of an unrealistic outcome.

2 Answers available

How would you approach post-operative VTE prophylaxis for renal transplant in patients with a prior history of provoked VTE?

Are there specific guidelines for managing this patient population?

1 Answer available

For patients with suspected complement-mediated TMA, are there specific clinical or laboratory parameters that can help guide the decision for starting empirical treatment (e.g., eculizumab) while awaiting the results of complement testing?

1 Answer available

How do you manage patients blood pressures while on anti-angiogenic TKIs?

Do you insist on ambulatory/home blood pressures to rule in/out white coat hypertension? Does your practice have a system to log patients' BPs to supp...

1 Answer available

Do you recommend preloading with IV magnesium to decrease the risk of cisplatin nephrotoxicity?

3 Answers available

What is your strategy for managing immunosuppression in patients with a kidney transplant who develop metastatic cancer?

3 Answers available

Do you hold IV iron in the setting of active infection?

1 Answer available

In which patients with atypical HUS would you consider eculizumab discontinuation?

Given the high cost of eculizumab, are there patient characteristics that inform which patients, if any, should be on indefinite therapy versus a time...

2 Answers available